Miñana B, Rodríguez-Antolín A, Prieto M, Pedrosa E
Servicio de Urología, Hospital Morales Meseguer, Murcia, Cátedra de Urología de la Universidad Católica San Antonio de Murcia (UCAM), Murcia, España.
Actas Urol Esp. 2013 Oct;37(9):544-8. doi: 10.1016/j.acuro.2013.03.003. Epub 2013 Jul 12.
To analyse the severity profiles and progression criteria in patients diagnosed of benign prostatic hyperplasia (BPH) in urology clinics in Spain.
A multicentre observational epidemiological study conducted in Spain between May-November 2008. A representative sample of 392 urologist gathered socio-demographic, clinical and patient-centered data from three consecutive patients with new diagnostic of BPH in urology clinics.
A total of 1.115 patients were evaluated. Mean age was 65.7 years old. Mean time from the onset of symptoms to diagnostic was 18,8 months. Mean IPSS score was 17.2. 63 patients (5,7%) had mild symptoms; 670 (60,1%) had moderate symptoms with a mean IPSS score of 14.6 and 382 (34.3%) had severe symptoms with a mean IPSS score of 23.7. Mean PSA was 2.6 ng/ml and ultrasound measured prostatic volume was 49.2cc. A total of 713 (63,9%) patients met progression criteria (PSA >1.5 ng/ml and volume>30 cc). Symptoms severity was directly correlated with age, prostatic volume, PSA, presence of progression criteria and time from the onset of symptoms and inversely correlated with urine flow rate (P<.001). Progression criteria was directly correlated with age, symptoms severity and inversely with urine flow rate (P<.01).
More than 90% of patients diagnosed of BPH in urology clinics in Spain had moderate to severe symptoms. Two thirds met progression criteria that correlate with age and severity of symptoms.
分析西班牙泌尿外科诊所中诊断为良性前列腺增生(BPH)患者的严重程度概况及病情进展标准。
2008年5月至11月在西班牙进行的一项多中心观察性流行病学研究。392名泌尿科医生组成的代表性样本收集了来自泌尿外科诊所连续3例新诊断为BPH患者的社会人口统计学、临床及以患者为中心的数据。
共评估了1115例患者。平均年龄为65.7岁。从症状出现到诊断的平均时间为18.8个月。平均国际前列腺症状评分(IPSS)为17.2。63例(5.7%)患者有轻度症状;670例(60.1%)有中度症状,平均IPSS评分为14.6,382例(34.3%)有重度症状,平均IPSS评分为23.7。平均前列腺特异性抗原(PSA)为2.6 ng/ml,超声测量的前列腺体积为49.2立方厘米。共有713例(63.9%)患者符合病情进展标准(PSA>1.5 ng/ml且体积>30立方厘米)。症状严重程度与年龄、前列腺体积、PSA、病情进展标准的存在以及症状出现时间直接相关,并与尿流率呈负相关(P<0.001)。病情进展标准与年龄、症状严重程度直接相关,与尿流率呈负相关(P<0.01)。
在西班牙泌尿外科诊所诊断为BPH的患者中,超过90%有中度至重度症状。三分之二符合与年龄和症状严重程度相关的病情进展标准。